A detailed history of Capital International Sarl transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital International Sarl holds 64,970 shares of EW stock, worth $4.86 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
64,970
Previous 56,855 14.27%
Holding current value
$4.86 Million
Previous $5.25 Million 18.36%
% of portfolio
0.12%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $484,465 - $761,024
8,115 Added 14.27%
64,970 $4.29 Million
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $472,585 - $528,701
-5,606 Reduced 8.98%
56,855 $5.25 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $1.28 Million - $1.69 Million
-17,656 Reduced 22.04%
62,461 $5.97 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $5.59 Million - $7.04 Million
-90,546 Reduced 53.06%
80,117 $6.11 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $122,972 - $165,749
-1,775 Reduced 1.03%
170,663 $11.8 Million
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $1.19 Million - $1.38 Million
14,653 Added 9.29%
172,438 $16.3 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $4.92 Million - $5.6 Million
66,237 Added 72.35%
157,785 $13.1 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $924,782 - $1.18 Million
13,540 Added 17.36%
91,548 $6.83 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $635,237 - $827,420
7,712 Added 10.97%
78,008 $6.45 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $2.21 Million - $3.28 Million
-25,571 Reduced 26.67%
70,296 $6.68 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $243,480 - $306,475
2,388 Added 2.55%
95,867 $11.3 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $4.36 Million - $5.36 Million
40,994 Added 78.11%
93,479 $12.1 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $444,777 - $530,525
-4,322 Reduced 7.61%
52,485 $5.94 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $884,092 - $1.1 Million
10,545 Added 22.79%
56,807 $5.88 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $1.23 Million - $1.42 Million
15,610 Added 50.93%
46,262 $3.87 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $425,336 - $541,267
5,933 Added 24.0%
30,652 $2.8 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $32,251 - $41,971
480 Added 1.98%
24,719 $1.97 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $935,255 - $1.25 Million
16,254 Added 203.56%
24,239 $1.68 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $691,025 - $1.07 Million
-13,185 Reduced 62.28%
7,985 $1.51 Million
Q4 2019

Feb 18, 2020

BUY
$71.7 - $82.09 $101,814 - $116,567
1,420 Added 7.19%
21,170 $4.94 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $1.22 Million - $1.49 Million
19,750 New
19,750 $4.34 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.